Nutra Pharma Corp: Growing Biopharma Focus on Pain, Cancer and Autoimmune Markets
Nutra Pharma Corp’s focus on acquiring and commercializing niche drug technologies, from pain to cancer, positions it as a small yet strategic biopharma player aiming to improve patient outcomes in the U.S. market.
2 minutes to read

